Skip to content

Comparison of efficacy of N -Acetyl cysteine Vs 3% Saline Vs Salbutamol in bronchiolitis

To compare efficacy of N-Acetylcysteine vs 3 % hypertonic saline vs Salbutamol in treatment of Acute Bronchiolitis in children aged 2 month to 24 months . - NNHS

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053894
Enrollment
120
Registered
2023-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J219- Acute bronchiolitis, unspecified

Interventions

Intervention1: Nebulisation with N-Acetylcysteine: Nebulisation with N-Acetylcysteine in the treatment of acute bronchiolitis in children aged 2 to 24 months. Intervention2: Nebulisation with 3% Hyper

Sponsors

Motilal Nehru Medical College Prayagraj Uttar Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hospitalized children,aged 2 to 24 month with clinical diagnosis of acute bronchiolitis. 2.Clinical severity score >3.

Exclusion criteria

Exclusion criteria: 1.History of N-Acetylcysteine and corticosteroid intake in last 4 week. 2.Chronic cardiopulmonary disease eg.congenital heart disease or chronic lung disease. 3.Known immunodeficiency state. 4.Family history of atopy,history of recurrent nebulization. 5.History of mechanical ventilation in neonatal period. 6.Critically sick patients at time of admission.

Design outcomes

Primary

MeasureTime frame
Primary outcome will be in form of day of clinical improvement according to clinical severity scoring (score3).Timepoint: 1 year

Secondary

MeasureTime frame
1.Total length of hospital stay. 2.Patients requiring bronchodilator in N-Acetylcysteine group and 3% hypertonic saline group. 3.Patients requiring CPAP support in each group and the day of start of it. 4.Side effects of nebulised drugs.Timepoint: 1 year

Countries

India

Contacts

Public ContactBhupendra Kumar

Motilal Nehru Medical College Prayagraj

mukeshvirsingh@gmail.com9456630304

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026